Selected research
Industry Research
Genetically Modified Animal Models Industry Research Report 2026
Market perspective
The global Genetically Modified Animal Models market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Genetically Modified Animal Models market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Genetically Modified Animal Models market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Genetically Modified Animal Models market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Genetically Modified Animal Models include ModelOrg, GemPharmatech, Cyagen Biosciences, Biocytogen, JOINN, China Environmental Technology and Bioenergy, Charles River, Taconic Biosciences and GenOway, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Genetically Modified Animal Models market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Genetically Modified Animal Models.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Genetically Modified Animal Models Market by Company
ModelOrg
GemPharmatech
Cyagen Biosciences
Biocytogen
JOINN
China Environmental Technology and Bioenergy
Charles River
Taconic Biosciences
GenOway
CLEA Japan
Ozgene
InVivo Biosystems
Harbour BioMed
PolyGene
Genetically Modified Animal Models Segment by Type
Rodents
Non-Human Primates
Zebrafish
Others
Genetically Modified Animal Models Segment by Application
Universities
Hospitals
Pharmaceutical Companies
Others
Genetically Modified Animal Models Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Animal Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Animal Models and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Animal Models.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genetically Modified Animal Models companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rodents
- Non-Human Primates
- Zebrafish
- Others
Applications
- Universities
- Hospitals
- Pharmaceutical Companies
- Others
Companies covered
- ModelOrg
- GemPharmatech
- Cyagen Biosciences
- Biocytogen
- JOINN
- China Environmental Technology and Bioenergy
- Charles River
- Taconic Biosciences
- GenOway
- CLEA Japan
- Ozgene
- InVivo Biosystems
- Harbour BioMed
- PolyGene
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Genetically Modified Animal Models by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Rodents
- 2.2.3 Non-Human Primates
- 2.2.4 Zebrafish
- 2.2.5 Others
- 2.3 Genetically Modified Animal Models by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Universities
- 2.3.3 Hospitals
- 2.3.4 Pharmaceutical Companies
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Genetically Modified Animal Models Breakdown Data by Type
- 3.1 Global Genetically Modified Animal Models Historic Market Size by Type (2021-2026)
- 3.2 Global Genetically Modified Animal Models Forecasted Market Size by Type (2027-2032)
4 Genetically Modified Animal Models Breakdown Data by Application
- 4.1 Global Genetically Modified Animal Models Historic Market Size by Application (2021-2026)
- 4.2 Global Genetically Modified Animal Models Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Genetically Modified Animal Models Market Perspective (2021-2032)
- 5.2 Global Genetically Modified Animal Models Growth Trends by Region
- 5.2.1 Global Genetically Modified Animal Models Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Genetically Modified Animal Models Historic Market Size by Region (2021-2026)
- 5.2.3 Genetically Modified Animal Models Forecasted Market Size by Region (2027-2032)
- 5.3 Genetically Modified Animal Models Market Dynamics
- 5.3.1 Genetically Modified Animal Models Industry Trends
- 5.3.2 Genetically Modified Animal Models Market Drivers
- 5.3.3 Genetically Modified Animal Models Market Challenges
- 5.3.4 Genetically Modified Animal Models Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Genetically Modified Animal Models Players by Revenue
- 6.1.1 Global Top Genetically Modified Animal Models Players by Revenue (2021-2026)
- 6.1.2 Global Genetically Modified Animal Models Revenue Market Share by Players (2021-2026)
- 6.2 Global Genetically Modified Animal Models Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Genetically Modified Animal Models Head Office and Area Served
- 6.4 Global Genetically Modified Animal Models Players, Product Type & Application
- 6.5 Global Genetically Modified Animal Models Manufacturers Established Date
- 6.6 Global Genetically Modified Animal Models Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Genetically Modified Animal Models Market Size (2021-2032)
- 7.2 North America Genetically Modified Animal Models Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Genetically Modified Animal Models Market Size by Country (2021-2026)
- 7.4 North America Genetically Modified Animal Models Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Genetically Modified Animal Models Market Size (2021-2032)
- 8.2 Europe Genetically Modified Animal Models Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Genetically Modified Animal Models Market Size by Country (2021-2026)
- 8.4 Europe Genetically Modified Animal Models Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Genetically Modified Animal Models Market Size (2021-2032)
- 9.2 Asia-Pacific Genetically Modified Animal Models Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Genetically Modified Animal Models Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Genetically Modified Animal Models Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Genetically Modified Animal Models Market Size (2021-2032)
- 10.2 South America Genetically Modified Animal Models Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Genetically Modified Animal Models Market Size by Country (2021-2026)
- 10.4 South America Genetically Modified Animal Models Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Genetically Modified Animal Models Market Size (2021-2032)
- 11.2 Middle East & Africa Genetically Modified Animal Models Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Genetically Modified Animal Models Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ModelOrg
- 12.1.1 ModelOrg Company Information
- 12.1.2 ModelOrg Business Overview
- 12.1.3 ModelOrg Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.1.4 ModelOrg Genetically Modified Animal Models Product Portfolio
- 12.1.5 ModelOrg Recent Developments
- 12.2 GemPharmatech
- 12.2.1 GemPharmatech Company Information
- 12.2.2 GemPharmatech Business Overview
- 12.2.3 GemPharmatech Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.2.4 GemPharmatech Genetically Modified Animal Models Product Portfolio
- 12.2.5 GemPharmatech Recent Developments
- 12.3 Cyagen Biosciences
- 12.3.1 Cyagen Biosciences Company Information
- 12.3.2 Cyagen Biosciences Business Overview
- 12.3.3 Cyagen Biosciences Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.3.4 Cyagen Biosciences Genetically Modified Animal Models Product Portfolio
- 12.3.5 Cyagen Biosciences Recent Developments
- 12.4 Biocytogen
- 12.4.1 Biocytogen Company Information
- 12.4.2 Biocytogen Business Overview
- 12.4.3 Biocytogen Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.4.4 Biocytogen Genetically Modified Animal Models Product Portfolio
- 12.4.5 Biocytogen Recent Developments
- 12.5 JOINN
- 12.5.1 JOINN Company Information
- 12.5.2 JOINN Business Overview
- 12.5.3 JOINN Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.5.4 JOINN Genetically Modified Animal Models Product Portfolio
- 12.5.5 JOINN Recent Developments
- 12.6 China Environmental Technology and Bioenergy
- 12.6.1 China Environmental Technology and Bioenergy Company Information
- 12.6.2 China Environmental Technology and Bioenergy Business Overview
- 12.6.3 China Environmental Technology and Bioenergy Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.6.4 China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio
- 12.6.5 China Environmental Technology and Bioenergy Recent Developments
- 12.7 Charles River
- 12.7.1 Charles River Company Information
- 12.7.2 Charles River Business Overview
- 12.7.3 Charles River Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.7.4 Charles River Genetically Modified Animal Models Product Portfolio
- 12.7.5 Charles River Recent Developments
- 12.8 Taconic Biosciences
- 12.8.1 Taconic Biosciences Company Information
- 12.8.2 Taconic Biosciences Business Overview
- 12.8.3 Taconic Biosciences Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.8.4 Taconic Biosciences Genetically Modified Animal Models Product Portfolio
- 12.8.5 Taconic Biosciences Recent Developments
- 12.9 GenOway
- 12.9.1 GenOway Company Information
- 12.9.2 GenOway Business Overview
- 12.9.3 GenOway Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.9.4 GenOway Genetically Modified Animal Models Product Portfolio
- 12.9.5 GenOway Recent Developments
- 12.10 CLEA Japan
- 12.10.1 CLEA Japan Company Information
- 12.10.2 CLEA Japan Business Overview
- 12.10.3 CLEA Japan Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.10.4 CLEA Japan Genetically Modified Animal Models Product Portfolio
- 12.10.5 CLEA Japan Recent Developments
- 12.11 Ozgene
- 12.11.1 Ozgene Company Information
- 12.11.2 Ozgene Business Overview
- 12.11.3 Ozgene Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.11.4 Ozgene Genetically Modified Animal Models Product Portfolio
- 12.11.5 Ozgene Recent Developments
- 12.12 InVivo Biosystems
- 12.12.1 InVivo Biosystems Company Information
- 12.12.2 InVivo Biosystems Business Overview
- 12.12.3 InVivo Biosystems Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.12.4 InVivo Biosystems Genetically Modified Animal Models Product Portfolio
- 12.12.5 InVivo Biosystems Recent Developments
- 12.13 Harbour BioMed
- 12.13.1 Harbour BioMed Company Information
- 12.13.2 Harbour BioMed Business Overview
- 12.13.3 Harbour BioMed Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.13.4 Harbour BioMed Genetically Modified Animal Models Product Portfolio
- 12.13.5 Harbour BioMed Recent Developments
- 12.14 PolyGene
- 12.14.1 PolyGene Company Information
- 12.14.2 PolyGene Business Overview
- 12.14.3 PolyGene Revenue in Genetically Modified Animal Models Business (2021-2026)
- 12.14.4 PolyGene Genetically Modified Animal Models Product Portfolio
- 12.14.5 PolyGene Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst